As of Aug 28
| -0.02 / -5.13%|
The 1 analysts offering 12-month price forecasts for Taxus Cardium Pharmaceuticals Group Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a +440.53% increase from the last price of 0.37.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.